The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1421
ISSUE 1421
July 22, 2013
Issue 1421
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Brinzolamide/Brimonidine (Simbrinza) for Glaucoma
July 22, 2013 (Issue: 1421)
The FDA has approved Simbrinza (Alcon), an ophthalmic
combination of the carbonic anhydrase inhibitor
brinzolamide and the selective alpha2-adrenergic
receptor agonist brimonidine, for reduction of intraocular
pressure (IOP) in patients with...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.